Device Medical Device

(5153) Azurion 5 M20 Gc

Payments companies reported to CMS as associated with (5153) Azurion 5 M20 Gc. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$3,604associated payments (2023-2025)

37clinicians with associated payments

2companies reporting

By year

2023 $1,294

2024 $2,310

Payments reported as associated with (5153) Azurion 5 M20 Gc, per program year, as reported to CMS.

Who makes it

Philips North America LLC $2,310 associated with (5153) Azurion 5 M20 Gc (2023-2025)
Philips Electronics North America Corporation $1,294 associated with (5153) Azurion 5 M20 Gc (2023-2025)

Specialties most often involved

Interventional Cardiology $1,373

Cardiovascular Disease $949

Clinical Cardiac Electrophysiology $321

Vascular & Interventional Radiology $300

Internal Medicine $114

Vascular Surgery $109

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with (5153) Azurion 5 M20 Gc

These are the largest totals companies reported as associated with (5153) Azurion 5 M20 Gc. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Ahmad Aslam	Tomball, TX	Cardiovascular Disease	$282.21
Amanda Ryan	Carlsbad, NM	Interventional Cardiology	$206.75
Anderson Mehrle	Bartlesville, OK	Cardiovascular Disease	$156.43
Matthew Bunte	Kansas City, MO	Interventional Cardiology	$147.71
Rahul Bose	New Braunfels, TX	Interventional Cardiology	$146.32
Gilad Birnbaum	New Braunfels, TX	Clinical Cardiac Electrophysiology	$146.31
Jamison Wyatt	New Braunfels, TX	Interventional Cardiology	$146.31
Vishwanatha Nadig	De Queen, AR	Interventional Cardiology	$130.56
Michael Gen	Virginia Beach, VA	Interventional Cardiology	$130.56
Jeffery Tauth	Hot Springs National Park, AR	Interventional Cardiology	$122.29

Prescribed (5153) Azurion 5 M20 Gc?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.